We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1B
AUM Growth
-$10.2M
Cap. Flow
-$19.8M
Cap. Flow %
-1.98%
Top 10 Hldgs %
3.73%
Holding
2,077
New
647
Increased
422
Reduced
386
Closed
620

Top Buys

Rank Stock Value
1
WEN icon
Wendy's
WEN
+$4.1M
2
DMC
Del Monte Corp
DMC
+$3.08M
3
SONO icon
Sonos
SONO
+$2.84M
4
IDXX icon
Idexx Laboratories
IDXX
+$2.8M
5
JBSS icon
John B. Sanfilippo & Son
JBSS
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 15.64%
2 Consumer Discretionary 14.23%
3 Healthcare 13.56%
4 Financials 11.82%
5 Industrials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRWD icon
551
Ironwood Pharmaceuticals
IRWD
$711M
$677K 0.07%
63,606
-39,652
-38% -$426K
WRLD icon
552
World Acceptance Corp
WRLD
$872M
$674K 0.07%
+5,027
New +$541K
ALDX icon
553
Aldeyra Therapeutics
ALDX
$93.5M
$669K 0.07%
79,707
-13,237
-14% -$130K
FHN icon
554
First Horizon
FHN
$12.1B
$669K 0.07%
59,396
-63,065
-51% -$845K
KMX icon
555
CarMax
KMX
$8.26B
$669K 0.07%
7,992
+2,664
+50% +$195K
RLMD icon
556
Relmada Therapeutics
RLMD
$519M
$668K 0.07%
271,524
+208,926
+334% +$578K
DOLE icon
557
Dole
DOLE
$1.32B
$667K 0.07%
49,361
+36,915
+297% +$473K
ZTS icon
558
Zoetis
ZTS
$30.5B
$667K 0.07%
3,873
+2,506
+183% +$433K
IMGN
559
DELISTED
Immunogen Inc
IMGN
$667K 0.07%
35,364
+5,564
+19% +$65.7K
SCU
560
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$667K 0.07%
75,586
-41,063
-35% -$357K
AXNX
561
DELISTED
Axonics, Inc. Common Stock
AXNX
$664K 0.07%
13,150
+7,134
+119% +$380K
DDOG icon
562
Datadog
DDOG
$83.3B
$663K 0.07%
6,738
-521
-7% -$43.6K
HCI icon
563
HCI Group
HCI
$2.41B
$663K 0.07%
10,730
-528
-5% -$29K
CLDT
564
Chatham Lodging
CLDT
$586M
$662K 0.07%
70,747
+57,506
+434% +$569K
FIGS icon
565
FIGS
FIGS
$2.38B
$662K 0.07%
+79,991
New +$608K
GTHX
566
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$662K 0.07%
+266,017
New +$727K
SYBT icon
567
Stock Yards Bancorp
SYBT
$2.6B
$659K 0.07%
+14,528
New +$680K
LMNR icon
568
Limoneira
LMNR
$251M
$657K 0.07%
+42,252
New +$696K
OSW icon
569
OneSpaWorld
OSW
$2.66B
$657K 0.07%
54,334
-3,879
-7% -$44.8K
RAPT
570
DELISTED
RAPT Therapeutics
RAPT
$657K 0.07%
4,393
+598
+16% +$93.1K
SHCO
571
DELISTED
Soho House & Co
SHCO
$655K 0.07%
120,781
-179,508
-60% -$1.13M
INTC icon
572
Intel
INTC
$513B
$653K 0.07%
19,535
-3,003
-13% -$94.3K
AVAH icon
573
Aveanna Healthcare
AVAH
$2.07B
$652K 0.07%
385,510
-113,548
-23% -$142K
PWR icon
574
Quanta Services
PWR
$101B
$652K 0.07%
+3,319
New +$579K
BKD icon
575
Brookdale Senior Living
BKD
$3.4B
$648K 0.06%
+153,440
New +$593K

Similar funds

GSA Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, GSA Capital Partners held 2,077 positions worth $1B, down 1% from $1.01B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners's Q2 2023 filing shows 647 new, 422 increased, 386 reduced and 620 closed positions. Its largest new stake was Sonos: 160,082 shares worth $2.61M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $7.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • GSA Capital Partners's largest Q2 2023 buy was Sonos: 160,082 shares worth $2.61M.
  • GSA Capital Partners added most to Wendy's in Q2 2023, an estimated $4.1M increase.
  • GSA Capital Partners's biggest Q2 2023 reduction was Arlo Technologies, cutting an estimated $3.67M.
  • GSA Capital Partners fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2023, selling an estimated $7.8M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $1B portfolio in Q2 2023.
  • GSA Capital Partners opened 647 new positions and closed 620 in Q2 2023.
  • GSA Capital Partners's portfolio value fell 1% quarter-over-quarter to $1B.

Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.